Fresh Recalls

FDAClass II · Medical device · Recall Z-2768-2026 · Recalled July 29, 2026

Ventriculostomy Kit recall — Medtronic Neurosurgery

Agency report date: July 29, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Ventriculostomy Kit
Company / brand
Medtronic Neurosurgery
Lot / serial / date codes
UDI-DI: 00673978947396, Lot: 2025-08779
Distribution
Worldwide - US Nationwide distribution in the states of UT, AL, CA, NC, GA, AR, LA, KY, LA, KY, IL, OK and the country of Costa Rica.
Agency product description and boundaries

Ventriculostomy Kit, REF: 46154

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Ventriculostomy devices, used during ventriculostomy procedures to gain access to the ventricular system, may exhibit endotoxin levels that exceed the acceptable limit for devices that come into contact with cerebrospinal fluid; endotoxin exposure can cause an acute inflammatory process.

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class II: may cause temporary or medically reversible health consequences.

Affected product: Ventriculostomy Kit

3. Open the official notice or contact

Official recall ID
Z-2768-2026
Brand
Medtronic Neurosurgery
Classification
Class II
Units affected
167
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Haltom City, TX, United States
Firm address
4620 N Beach St, N/A, 76137-3219

Identifying details (verbatim from the notice)

Product codes / lots
UDI-DI: 00673978947396, Lot: 2025-08779
Distribution
Worldwide - US Nationwide distribution in the states of UT, AL, CA, NC, GA, AR, LA, KY, LA, KY, IL, OK and the country of Costa Rica.
Firm notified the public via
Letter
FDA event ID
99342
Recall initiated
June 17, 2026
FDA classified
July 21, 2026
FDA report date
July 29, 2026
Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked September 7, 2026 at 6:00 AM UTC. Record retrieved September 7, 2026 at 6:00 AM UTC.

Report a data error on this page